(Q43497594)

24 November 2017

title

Management of Hepatitis C in HIV-infected Patients (English)

1 reference

24 November 2017

Benigno Rodriguez

1

1 reference

24 November 2017

David A Bobak

series ordinal

2

1 reference

24 November 2017

publication date

1 March 2005

1 reference

Current infectious disease reports

24 November 2017

published in

1 reference

24 November 2017

volume

7

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

91-102

1 reference

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Relation between HIV-1 and hepatitis C viral load in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Hepatitis C virus infection in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

HCV replication in PBMC and its influence on interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0067-0

Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C.

21 January 2018

1 reference

12 December 2020

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

12 December 2020

Care of patients with hepatitis C and HIV co-infection

1 reference

12 December 2020

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

1 reference

12 December 2020

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

1 reference

12 December 2020

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

1 reference

12 December 2020

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection

1 reference

12 December 2020

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

12 December 2020

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients

1 reference

12 December 2020

The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy

1 reference

12 December 2020

Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses Transmission

1 reference

12 December 2020

Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999

1 reference

12 December 2020

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

1 reference

12 December 2020

Hepatitis C and progression of HIV disease

1 reference

12 December 2020

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

1 reference

12 December 2020

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

12 December 2020

An IFN-beta-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates

1 reference

12 December 2020

HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?

1 reference

12 December 2020

Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C.

1 reference

12 December 2020

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

12 December 2020

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

12 December 2020

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

12 December 2020

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

12 December 2020

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

1 reference

12 December 2020

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

1 reference

12 December 2020

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

1 reference

12 December 2020

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature

1 reference

12 December 2020

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

1 reference

12 December 2020

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

12 December 2020

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

12 December 2020

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

1 reference

12 December 2020

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

12 December 2020

Sertraline treatment of interferon-alfa-induced depressive disorder

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys

1 reference

12 December 2020

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

12 December 2020

Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review

1 reference

12 December 2020

Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.

1 reference

12 December 2020

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

12 December 2020

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

12 December 2020

Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

1 reference

12 December 2020

Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but No HCV DNA despite evidence for reverse transcription of HIV RNA into DNA.

1 reference

12 December 2020

Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients

1 reference

12 December 2020

Hepatitis C and human immunodeficiency virus infection

1 reference

12 December 2020

Five cases of interferon-alpha-induced depression treated with antidepressant therapy

1 reference

12 December 2020

Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study

1 reference

12 December 2020

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

1 reference

12 December 2020

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

1 reference

12 December 2020

Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

1 reference

12 December 2020

Transfusion-associated hepatitis and AIDS. What is the risk?

1 reference

12 December 2020

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.

1 reference

12 December 2020

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

12 December 2020

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

12 December 2020

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease

1 reference

12 December 2020

Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy

1 reference

12 December 2020

CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals

1 reference

12 December 2020

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

12 December 2020

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

1 reference

12 December 2020

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection

1 reference

12 December 2020

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

1 reference

12 December 2020

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

12 December 2020

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

1 reference

12 December 2020

HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury

1 reference

12 December 2020

Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study

1 reference

12 December 2020

Ribavirin antagonizes the effect of azidothymidine on HIV replication

1 reference

12 December 2020

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

1 reference

12 December 2020

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

1 reference

12 December 2020

Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.

1 reference

12 December 2020

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

1 reference

12 December 2020

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

1 reference

12 December 2020

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals

1 reference

12 December 2020

Fluoxetine treatment of depression caused by interferon-alpha.

1 reference

12 December 2020

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

12 December 2020

Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.

1 reference

12 December 2020

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985

1 reference

12 December 2020

The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients

1 reference

12 December 2020

HIV Infection, hepatitis C infection, and HAART: hard clinical choices

1 reference

12 December 2020

Liver transplantation in patients with HIV infection

1 reference

12 December 2020

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

1 reference

12 December 2020

Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival

1 reference

12 December 2020

Hepatitis C--global prevalence (update)

1 reference

12 December 2020

HIV/HCV coinfection, HAART, and liver-related mortality

1 reference

12 December 2020

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue

1 reference

12 December 2020

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

1 reference

12 December 2020

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients

1 reference

12 December 2020

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

12 December 2020

Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study

1 reference

12 December 2020

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

1 reference

12 December 2020

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

12 December 2020

10.1007/S11908-005-0067-0

Identifiers

DOI

1 reference

24 November 2017

1 reference